|
|
|
Vera Afreixo, Ana Helena Tavares, Vera Enes, Miguel Pinheiro, Leonor Rodrigues and Gabriela Moura
In this work, we aimed to establish a stable and accurate procedure with which to perform feature selection in datasets with a much higher number of predictors than individuals, as in genome-wide association studies. Due to the instability of feature sel...
ver más
|
|
|
|
|
|
|
Miranda Bellezza, Azzurra di Palma and Andrea Frosini
Alzheimer?s disease (AD) is a neurodegenerative disorder that leads to the loss of cognitive functions due to the deterioration of brain tissue. Current diagnostic methods are often invasive or costly, limiting their widespread use. Developing non-invasi...
ver más
|
|
|
|
|
|
|
Md Easin Hasan and Amy Wagler
Neuroimaging experts in biotech industries can benefit from using cutting-edge artificial intelligence techniques for Alzheimer?s disease (AD)- and dementia-stage prediction, even though it is difficult to anticipate the precise stage of dementia and AD....
ver más
|
|
|
|
|
|
|
Artur Chudzik and Andrzej W. Przybyszewski
Neurodegenerative diseases (NDs), including Parkinson?s and Alzheimer?s disease, pose a significant challenge to global health, and early detection tools are crucial for effective intervention. The adaptation of online screening forms and machine learnin...
ver más
|
|
|
|
|
|
|
Naghmeh Jafarpournaser, Mahmoud Reza Delavar and Maryam Noroozian
The increasing prevalence of cognitive disorders among the elderly is a significant consequence of the global aging phenomenon. Wandering stands out as the most prominent and challenging symptom in these patients, with potential irreversible consequences...
ver más
|
|
|
|
|
|
|
You Sheng Toh and Carol Anne Hargreaves
Extensive medical research has revealed evidence of a strong association between hippocampus atrophy and age-related diseases such as Alzheimer?s disease (AD). Therefore; segmentation of the hippocampus is an important task that can help clinicians and r...
ver más
|
|
|
|
|
|
|
Xiaoli Yang, Yuxin Xia, Zhenwei Li, Lipei Liu, Zhipeng Fan and Jiayi Zhou
Alzheimer?s disease (AD) is one of the most common irreversible brain diseases in the elderly. Mild cognitive impairment (MCI) is an early symptom of AD, and the early intervention of MCI may slow down the progress of AD. However, due to the subtle neuro...
ver más
|
|
|
|
|
|
|
Zeyuan Zhao, Ping Li, Yongjie Dai, Zhaoe Min and Lei Chen
Alzheimer?s disease (AD) is an irreversible neurodegenerative disease. Providing trustworthy AD progression predictions for at-risk individuals contributes to early identification of AD patients and holds significant value in discovering effective treatm...
ver más
|
|
|
|
|
|
|
Zhiqiong Wang, Zican Lin, Shuo Li, Yibo Wang, Weiying Zhong, Xinlei Wang and Junchang Xin
Alzheimer?s disease (AD) is a progressive, irreversible neurodegenerative disorder that requires early diagnosis for timely treatment. Functional magnetic resonance imaging (fMRI) is a non-invasive neuroimaging technique for detecting brain activity. To ...
ver más
|
|
|
|
|
|
|
Nayef Alqahtani, Shadab Alam, Ibrahim Aqeel, Mohammed Shuaib, Ibrahim Mohsen Khormi, Surbhi Bhatia Khan and Areej A. Malibari
Dementias that develop in older people test the limits of modern medicine. As far as dementia in older people goes, Alzheimer?s disease (AD) is by far the most prevalent form. For over fifty years, medical and exclusion criteria were used to diagnose AD,...
ver más
|
|
|
|